InvestorsHub Logo
Followers 117
Posts 9710
Boards Moderated 0
Alias Born 11/20/2013

Re: None

Friday, 03/20/2020 8:18:28 AM

Friday, March 20, 2020 8:18:28 AM

Post# of 58837
I recall someone saying they weren't working on a test kit... Hmmmm

ValuationCalendarAnalyst ReportsPeer ComparisonSEC Filings
Back to News Results
Applied DNA Shares Up; Co Working on Diagnostic Kit for Virus

7:39 am ET March 19, 2020 (Dow Jones) Print
By Michael Dabaie

Applied DNA Sciences Inc. shares were up 11% to $7.74 in premarket trading Thursday.

The company said it had completed the design of a diagnostic kit for the new coronavirus being developed for production via the company's proprietary PCR-based DNA manufacturing process.

The company earlier this month updated its collaborative progress with Takis Biotech, in Rome, Italy, on a series of LinearDNA vaccine candidates against the spike protein of SARS-CoV-2.

Applied DNA's diagnostic kit focuses on the gene that encodes the surface spike protein, an essential glycoprotein for viral entry into human host cells.

Applied DNA said no commercial partner has been identified to take the developmental diagnostic to market, nor is there any indication that the company's diagnostics would be approved by regulators.

Once fully validated and ready for shipment, the company said it plans to sell the diagnostic kit for research use only while awaiting the potential emergency use authorization by the U.S. Food and Drug Administration for sales to diagnostic labs.

Write to Michael Dabaie at michael.dabaie@wsj.com

(END) Dow Jones Newswires

March 19, 2020 07:39 ET (11:39 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.

The stock market is an predator / prey scenario where the Companies and their lenders are the predators and retail IS the prey. Play wisely!


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent APDN News